tradingkey.logo
Markets
News
Analysis
Tools
Learn
Stock Score
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo

Aerovate Therapeutics Inc

AVTE

2.680USD

0.000
Close 09/19, 16:00（ET）Quotes delayed by 15 min
77.68MMarket Cap
LossP/E TTM

Aerovate Therapeutics Inc

2.680

0.000
OverviewCompanyFinancialsAnalysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
Total equity
Cash, cash equivalents and short-term investments
--76.21M
--78.62M
- Cash and cash equivalents
--44.22M
--33.75M
-Short-term investments
--31.99M
--44.87M
Prepaid expenses
--318.00K
--649.00K
Other current assets
--845.00K
--845.00K
Total current assets
--77.37M
--80.12M
Non-current assets
Net Fixed Assets
--160.00K
--215.00K
Other non-current assets
--0.00
--0.00
Total assets
--77.53M
--80.33M
Liabilities
Current liabilities
-Other payables
--318.00K
--649.00K
Accrued expenses
--1.72M
--2.54M
Other current liabilities
--318.00K
--649.00K
Total current liabilities
--2.42M
--3.83M
Non-current liabilities
Long-term debt and lease liabilities
--0.00
--0.00
Other non-current liabilities
--70.00K
--70.00K
Total liabilities
--2.49M
--3.90M
Shareholders' equity
Common equity
--310.57M
--309.38M
Retained earnings
---235.57M
---233.05M
Capital reserves
--310.56M
--309.38M
Gains losses not affecting retained earnings
--50.00K
--105.00K
Total equity
--75.05M
--76.43M
Currency unit
USD
USD
Audit opinions
--
--
KeyAI